Global Pharmaceutical Demand And Automation Will Expand Distribution Reach

Published
19 Aug 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
US$180.46
17.9% undervalued intrinsic discount
20 Aug
US$148.10
Loading
1Y
35.3%
7D
-1.0%

Author's Valuation

US$180.5

17.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 20%

Shared on30 Apr 25
Fair value Increased 4.16%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Increased 0.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 0.38%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.60%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 20%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 2.09%